Diffuse glomerulosclerosis without tubular injury does not directly manifest renal dysfunction in nephrotic mice (ICGN strain)

Experimental Nephrology

Volumn 5, Issue 6, 1997, Pages 498-507

  Mizuno, Shinya ^a   Yue, Bing Fei ^a   Okamoto, Munehiro ^a   Horikawa, Yoko ^a   Kurosawa, Tsutomu ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Chronic renal disease; Glomerulosclerosis; Mouse model, renal dysfunction; Tubular injury

Indexed keywords

ALBUMIN; CREATININE; NITROGEN; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GLOMERULOSCLEROSIS; HYPOALBUMINEMIA; KIDNEY CORTEX; KIDNEY DISEASE; KIDNEY TUBULE DAMAGE; MALE; MOUSE; MOUSE STRAIN; NEPHROTIC SYNDROME; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA;

ACTINS; AGING; ALBUMINURIA; ANIMALS; BLOOD UREA NITROGEN; CREATININE; FEMALE; GLOMERULAR MESANGIUM; IMMUNOHISTOCHEMISTRY; KIDNEY; KIDNEY GLOMERULUS; KIDNEY TUBULES; MALE; MICE; MICE, MUTANT STRAINS; MUSCLE, SMOOTH; NEPHROSIS; SCLEROSIS; SERUM ALBUMIN;

EID: 0031455209     PISSN: 10187782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Brenner BM, Meyer TW, Hostetter TH: Dietary protein intake and the progressive nature of kidney disease: The role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N Engl J Med 1982;307:652-659.
2. Floege J, Burns MW, Alpers CE, Yoshimura A, Pritzl P, Gordon K, Seifert RA, Bowen PD, Couser WG, Johnson RJ: Glomerular cell proliferation and PDGF expression precede glomerulosclerosis in the remnant kidney model. Kidney Int 1992;41:297-309.
3. Bruijn JA, Roos A, Geus B, Heer E: Transforming growth factor-beta and the glomerular extracellular matrix in renal pathology. J Lab Clin Med 1994;123:34-47.
4. Wardle N: Glomerulosclerosis: The final pathway is clarified, but can we deal with the triggers? Nephron 1996;73:1-7.
5. Border WA, Okuda S, Languino LR, Sporn MB, Ruoslahti E: Suppression of experimental glomerulonephritis by antiserum against transforming growth factor beta I. Nature 1990;346: 371-374.
6. Border WA, Noble NA, Yamamoto T, Harper JR, Yamaguchi Y, Pierschbacher MD, Ruoslahti E: Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease. Nature 1992;360: 361-364.
7. Isaka Y, Brees DK, Ikegaya K, Kaneda Y, Imai E, Noble NA, Border WA: Gene therapy skeletal muscle expression of decorin prevents fibrotic disease in rat kidney. Nat Med 1996;2: 418-423.
8. Akagi Y, Isaka Y, Arai M, Kaneko T, Takenaka M, Moriyama T, Kaneda Y, Ando A, Orita Y, Kamada T, Ueda N, Imai E: Inhibition of TGF-beta 1 expression by antisense oligonucleotides suppressed extracellular matrix accumulation in experimental glomerulonephritis. Kidney Int 1996;50:148-155.
9. Wehrmann M, Bohle A, Bogenschütz O, Eissele R, Freislederer A, Ohlschlegel C, Schumm G, Batz C, Gartner HV: Long-term prognosis of chronic idiopathic membranous glomerulonephritis: An analysis of 334 cases with particular regard to tubulo-interstitial changes. Clin Nephrol 1989;31:67-76.
10. Mackensen HS, Bohle A, Christensen J, Wehrmann M, Kendziorra H, Kokot F: The consequences for renal function of widening of the interstitium and changes in the tubular epithelium of the renal cortex and outer medulla in various renal diseases. Clin Nephrol 1992;37: 70-77.
11. Wehrmann M, Bohle A, Held H, Schumm G, Kendziorra H, Pressler H: Long-term prognosis of focal sclerosing glomerulonephritis: An analysis of 250 cases with particular regard to tubulointerstitial changes. Clin Nephrol 1990; 33:115-122.
12. Alexopoulos E, Seron D, Hartley RB, Cameron JS: Lupus nephritis: Correlation of interstitial cells with glomerular function. Kidney Int 1990;37:100-109.
13. Lane PH, Steffes MW, Fioretto P, Mauer SM: Renal interstitial expansion in insulin dependent diabetes mellitus. Kidney Int 1993;43: 661-667.
14. Nath KA: Tubulointerstitial changes as a major determinant in the progression of renal damage. Am J Kidney Dis 1992;20:1-17.
15. Bohle A, Mackensen-Haen S, Gise H, Grund KE, Wehrmann M, Batz C, Bogenschütz O, Schmitt H, Nagy J, Müller C, Müller G: The consequences of tubulo-interstitial changes for renal function in glomerulopathies: A morphometric and cytological analysis. Pathol Res Pract 1990;186:135-144.
16. Bohle A, Strutz F, Müller GA: On the pathogenesis of chronic renal failure in primary glomerulopathies: A view from the interstitium. Exp Nephrol 1994;2:205-210.
17. Ong AC, Fine LG: Loss of glomerular function and tubulointerstitial fibrosis: Cause or effect? Kidney Int 1994;45:345-351.
18. Kurosawa T, Okamoto M, Yamada K, Yue BF: Nephrosis (nep): A new mouse mutation which causes albuminuria and other symptoms of nephrosis. Mouse Genome 1993;91:876-878.
19. Yamada K, Kurosawa T, Okamoto M, Yue BF, Mizuno S, Naiki M: Pathogenesis of spontaneous nephrosis in mice: Urinary protein in nephrotic mice (abstract). Exp Anim 1994;43: 527-534.
20. Tatsumi H, Satoh S, Okamoto M, Nakamura M, Asano T, Kurosawa T: Morphological studies on the kidney of the spontaneous nephrotic (ICGN) mice in the late stage. Acta Anat Nipponica 1995;70:96-106.
21. Raij LS, Azar S, Keane W: Mesangial immune injury, hypertension, and progressive glomerular damage in Dahl rats. Kidney Int 1984;26: 137-143.
22. Shih W, Hinbes WH, Neilson EG: Effects of cyclosporin A on the development of immunemediated interstitial nephritis. Kidney Int 1988;33:1113-1118.
23. Nakamura T, Ebihara I, Tomino Y, Koide H: Effect of a specific endothelin A receptor antagonist on murine lupus nephritis. Kidney Int 1995;47:481-489.
24. Ward JM, Stevens JL, Konishi N, Kurata Y, Uno H, Diwan BA, Ohmori T: Vimentin metaplasia in renal cortical tubules of preneoplastic, neoplastic, aging, and regenerative lesions of rats and humans. Am J Pathol 1992;141:955-964.
25. Igawa T, Matsumoto K, Kanda S, Saito Y, Nakamura T: Hepatocyte growth factor may function as a renotropic factor for regeneration in rats with acute renal injury. Am J Physiol 1993;265:F61-F69.
26. Ogura A, Fujimura H, Asano T, Koura M, Naito I, Kobayashi Y: Early ultrastructural glomerular alterations in neonatal nephrotic mice (ICGN strain). Vet Pathol 1995;32:321-323.
27. Floege J, Eng E, Young BA, Alpers CE, Barrett TB, Bowen PD, Johnson RJ: Infusion of platelet-derived growth factor or basic fibroblast growth factor induces selective glomerular mesangial cell proliferation and matrix accumulation in rats. J Clin Invest 1993;92:2952-2962.
28. Isaka Y, Fujiwara Y, Ueda N, Kaneda Y, Kamada T, Imai E: Glomerulosclerosis induced by in vivo transfection of transfoming growth factor-beta or platelet-derived growth factor gene into the rat kidney. J Clin Invest 1993;92: 2597-2601.
29. Arai M, Wada A, Isaka Y, Akagi Y, Sugiura T, Miyazaki M, Moriyama T, Kaneda Y, Naruse K, Naruse M, Orita Y, Ando A, Kamada T, Ueda N, Imai E: In vivo transfection of genes for renin and angiotensinogen into the glomerular cells induced phenotypic change of the mesangial cells and glomerular sclerosis. Biochem Biophys Res Commun 1995;206:525-532.
30. Studer RK, Craven PA, De Rubertis FR: Low-density lipoprotein stimulation of mesangial cell fibronectin synthesis: Role of protein kinase C and transforming growth factor-beta. J Lab Clin Med 1995;125:86-95.
31. Keane WF, Raji L: Relationship among altered glomerular barrier permselectivity, angiotensin II, and mesangial uptake of macromolecules. Lab Invest 1985;52:599-604.
32. Eddy AA, Giachelli CM: Renal expression of genes that promote interstitial inflammation and fibrosis in rats with protein-overload proteinuria. Kidney Int 1995;47:1546-1577.
33. Kees-Folts D, Sadow JL, Schreiner GF: Tubular catabolism of albumin is associated with the release of an inflammatory lipid. Kidney Int 1994;45:697-709.
34. Müller GA, Schettler V, Müller CA, Strutz F: Prevention of progression of renal fibrosis: How far are we? Kidney Int 1996;49(suppl 54): 75-82.
35. Burton CJ, Bevington A, Harris KP, Walls J: Growth of proximal tubular cells in the presence of albumin and proteinuric urine. Exp Nephrol 1994;2:345-350.
36. Fine L: The biology of renal hypertrophy. Kidney Int 1986;29:619-634.
37. Hosteller TH: Progression of renal disease and renal hypertrophy. Annu Rev Physiol 1995;57: 263-278.
38. +-ATPase in diabetes mellitus: Relationship to metabolic abnormality. Am J Physiol 1993;E96-E101.